Cost Effectiveness of Gene Expression Profile Testing in Community Practice

PURPOSE: Gene expression profile (GEP) testing can support chemotherapy decision making for patients with early-stage, estrogen receptor–positive, human epidermal growth factor 2–negative breast cancers. This study evaluated the cost effectiveness of one GEP test, Oncotype DX (Genomic Health, Redwoo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Chandler, Young, Schechter, Clyde B., Jayasekera, Jinani, Near, Aimee, O’Neill, Suzanne C., Isaacs, Claudine, Phelps, Charles E., Ray, G. Thomas, Lieu, Tracy A., Ramsey, Scott, Mandelblatt, Jeanne S.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2018
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815401/
https://ncbi.nlm.nih.gov/pubmed/29309250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.5034
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki